Clinical Trial Update: Study to Compare Maternal, Fetal, and Infant Outcomes of Women With Mild to Moderate Atopic Dermatitis Exposed to Ruxolitinib Cream During Pregnancy With an Unexposed Control Population

View source ↗

Summary

A clinical trial is recruiting to compare maternal, fetal, and infant outcomes in pregnant women with mild to moderate atopic dermatitis exposed to topical ruxo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Opzelura (ruxolitinib)

Snippet

Sponsor: Incyte Corporation | Conditions: Pregnancy Related, Atopic Dermatitis | Status: RECRUITING